Brown-Forman, US1170431092

Brown-Forman stock dips as Sazerac bid and Q1 FY27 figures shape outlook

Published on 09/17/2026 at 11:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Brown-Forman stock closed at USD 25.76 on the New York Stock Exchange on September 16, 2026, about 1.6% below the prior day’s close. The company’s Q1 fiscal 2027 revenue of USD 911 million and earnings of USD 176 million frame investor expectations after rejecting a USD 15 billion offer from Sazerac.

Fotorealistische Bourbon-Destillerie in Louisville KY mit Kupferstills und Eichenfässern
Brown-Forman Corp. US1170431092 zeigt eine authentische Bourbon-Destillerie in Louisville, Kentucky bei goldenem Abendsonnenlicht, Illustration mit AI erstellt.

Brown-Forman Corporation stock (ISIN US1170431092) closed at USD 25.76 for its BF.B share class on the New York Stock Exchange on September 16, 2026, down about 1.6% from the prior close of USD 26.18 according to data shown on Yahoo Finance as of that date. As of mid-September 2026, investors are weighing Q1 fiscal 2027 figures alongside news that Brown-Forman rebuffed a takeover approach from Sazerac that reportedly valued the company at about USD 15 billion.

Q1 fiscal 2027 figures set the earnings baseline

In its latest interim report for Q1 fiscal 2027, Brown-Forman generated revenue of USD 911 million and earnings of USD 176 million, providing the most recent detailed snapshot of operating performance within the past nine months and thus forming the current fundamental baseline for investors. These Q1 fiscal 2027 figures, highlighted in a mid-September overview of Brown-Forman’s financials, stand against trailing earnings per share of USD 1.55, underscoring the profitability of the company’s global spirits portfolio in the most recently reported period.

According to a summary of Brown-Forman’s fiscal 2027 guidance discussed on TipRanks on September 16, 2026, the company reaffirmed expectations for approximately flat organic net sales growth and a 3% to 5% decline in organic operating income for fiscal 2027. This means that, relative to the prior fiscal year’s organic operating income level, Brown-Forman currently anticipates that the operating result will be between 3% and 5% lower on an organic basis in fiscal 2027, a quantified comparison that explains why the market is cautious despite the solid brand portfolio.

Takeover interest from Sazerac adds strategic tension

Strategic interest in Brown-Forman is underlined by reports that Sazerac Co. made an offer valuing the company at about USD 15 billion, which the Brown-Forman board rejected earlier in the year. As Zonebourse reported on September 17, 2026, Sazerac’s offer for Brown-Forman, which was described as valuing the enterprise at about USD 15 billion, had been rejected by the company’s board in July as not acceptable.

Further context on the situation comes from coverage of Sazerac’s broader acquisition activity in the bourbon and spirits space. As Lexington Herald-Leader noted on September 16, 2026, Brown-Forman’s shares fell on the day amid discussion of Sazerac’s buying spree, and the newspaper reiterated that Brown-Forman had twice rebuffed a USD 15 billion bid earlier in the year after separate merger talks with Pernod Ricard did not result in a deal.

Market reaction to sector news and valuation context

Brown-Forman’s stock performance in mid-September 2026 is also being viewed in the context of broader sector moves tied to Sazerac’s acquisition plans. As Seeking Alpha reported on September 16, 2026, Brown-Forman’s BF.A and BF.B share classes fell around 2.2% as German schnapps maker Berentzen-Gruppe AG confirmed that it had entered talks to sell itself to Sazerac, indicating that investors see Sazerac’s moves as reshaping competitive dynamics across the spirits market.

From a valuation perspective, the USD 15 billion bid cited in media reports provides a concrete reference point against current market capitalization. A recent overview of Brown-Forman’s stock data indicated that, as of September 15, 2026, the company’s market capitalization stood at about USD 6,900,000,000 based on a BF.B closing price of USD 26.18 on the New York Stock Exchange, meaning the rejected Sazerac offer implied a valuation more than double that market cap at the time. This quantified gap between the indicated bid value and the prevailing market capitalization helps explain why speculation around strategic alternatives and control remains part of the Brown-Forman investment narrative.

Price levels and trading range as of mid-September 2026

Price data from Yahoo Finance on September 16, 2026 show Brown-Forman’s BF.B shares closing at USD 25.76 on the New York Stock Exchange, down 1.6% from the previous close of USD 26.18, with an intraday trading range between USD 25.55 and USD 26.49. The same overview lists the current price alongside analyst price targets, with a low target of USD 20.00, an average target near USD 28.26, and the current price of roughly USD 25.76, giving investors a concrete sense of how the stock trades relative to consensus expectations.

According to a stock data summary published on September 16, 2026, Brown-Forman’s BF.B shares most recently closed at USD 26.18 on September 15, 2026 before easing to USD 25.76 on September 16, 2026, representing a decline of about 1.6% day over day. The same dataset indicated a market capitalization of approximately USD 6.9 billion as of September 15, 2026, anchored by the New York Stock Exchange listing in USD, and this market cap figure provides a useful benchmark against the USD 15 billion valuation mentioned in connection with the Sazerac proposal.

Next earnings checkpoint and investor perspective

Investors looking ahead to Brown-Forman’s next detailed update are focusing on the upcoming quarter in fiscal 2027. A mid-September overview of Brown-Forman’s stock suggested an estimated next earnings date in early December 2026 for the BF.B share class, giving a rough indication of when the next quarterly release might be expected, though the date appeared as an estimate rather than a formally confirmed schedule.

For investors, the combination of Q1 fiscal 2027 revenue of USD 911 million, earnings of USD 176 million, and guidance indicating a 3% to 5% organic operating income decline for fiscal 2027 provides a clear, quantified framework for assessing Brown-Forman’s near-term prospects. When set against the rejected USD 15 billion offer from Sazerac and the current market capitalization of about USD 6.9 billion as of September 15, 2026, the stock’s closing price of USD 25.76 on September 16, 2026 reflects both the company’s brand strength and the market’s caution around earnings headwinds in fiscal 2027.

Brown-Forman stock price and key data

At the most recent completed session on the New York Stock Exchange, Brown-Forman’s BF.B shares closed at USD 25.76 on September 16, 2026, with the prior close at USD 26.18 and a daily percentage decline of about 1.6% in USD terms. This price level, paired with an indicated market capitalization near USD 6,900,000,000 as of September 15, 2026, situates Brown-Forman stock materially below the valuation implied by the rejected USD 15 billion bid while leaving room for investors to reassess the company’s earnings trajectory as fiscal 2027 unfolds.

Brown-Forman stock - key facts

  • Company: Brown-Forman Corporation
  • ISIN: US1170431092
  • Ticker: BF.B
  • Trading venue: NYSE
  • Price (as of September 16, 2026, 16:00): 25.76 USD
  • Market capitalization: 6,900,000,000 USD (as of September 15, 2026)
  • Sector / Industry: Beverages / Spirits
  • Index membership: S&P 500

More news and analyses on Brown-Forman stock

Disclaimer...

en | US1170431092 | BROWN-FORMAN | boerse | 70116721 | bgmi